These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37585297)

  • 1. Generation of epitope tag knock-in mice with CRISPR-Cas9 to study the function of endogenous proteins.
    Zhang Z
    STAR Protoc; 2023 Sep; 4(3):102518. PubMed ID: 37585297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Flag/DYKDDDDK Epitope Tag Knock-In Mice Using
    Aoto K; Takabayashi S; Mutoh H; Saitsu H
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas9-mediated insertion of a short artificial intron for the generation of conditional alleles in mice.
    Cassidy A; Pelletier S
    STAR Protoc; 2023 Mar; 4(1):102116. PubMed ID: 36853660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generating mutant
    Li HH; Li JC; Su MP; Liu KL; Chen CH
    STAR Protoc; 2021 Jun; 2(2):100432. PubMed ID: 33899015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized protocols for efficient gene editing in mouse hepatocytes
    Chen Y; Ding Q
    STAR Protoc; 2022 Mar; 3(1):101062. PubMed ID: 35005644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for efficient CRISPR-Cas9-mediated fluorescent tag knockin in hard-to-transfect erythroid cell lines.
    Deleuze V; Soler E; Andrieu-Soler C
    STAR Protoc; 2024 Jun; 5(2):103016. PubMed ID: 38640065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting endogenous proteins for spatial and temporal knockdown using auxin-inducible degron in Caenorhabditis elegans.
    Kurashina M; Mizumoto K
    STAR Protoc; 2023 Mar; 4(1):102028. PubMed ID: 36640369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA and Protein Interactomes of an RNA-Binding Protein Tagged with FLAG Epitopes Using Combinatory Approaches of Genome Engineering and Stable Transfection.
    Cheng S; Park M; Yong J
    Methods Mol Biol; 2023; 2666():247-263. PubMed ID: 37166670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology.
    Qiu Y; Ding Q
    STAR Protoc; 2021 Mar; 2(1):100307. PubMed ID: 33554142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protocol for efficient CRISPR-Cas9-mediated knock-in in colorectal cancer patient-derived organoids.
    Okamoto T; Natsume Y; Yamanaka H; Fukuda M; Yao R
    STAR Protoc; 2021 Dec; 2(4):100780. PubMed ID: 34585151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system.
    Farooq U; Notani D
    STAR Protoc; 2021 Dec; 2(4):100857. PubMed ID: 34746853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for CRISPR-Cas9-mediated genome editing to study spermatogenesis in Caenorhabditis elegans.
    Wang P; Cao Z; Wang Q; Ma X; Wang N; Chen L; Zhao Y; Miao L
    STAR Protoc; 2023 Dec; 4(4):102720. PubMed ID: 37967017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent tagging of endogenous proteins with CRISPR/Cas9 in primary mouse neural stem cells.
    Morrow CS; Porter TJ; Moore DL
    STAR Protoc; 2021 Sep; 2(3):100744. PubMed ID: 34430917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines.
    Gao P; Dong X; Wang Y; Wei GH
    STAR Protoc; 2021 Jun; 2(2):100419. PubMed ID: 33870225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A user-friendly and streamlined protocol for CRISPR/Cas9 genome editing in budding yeast.
    Novarina D; Koutsoumpa A; Milias-Argeitis A
    STAR Protoc; 2022 Jun; 3(2):101358. PubMed ID: 35712010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing.
    Ten Hacken E; Gruber M; Hernández-Sánchez M; Hoffmann GB; Baranowski K; Redd RA; Clement K; Livak K; Wu CJ
    STAR Protoc; 2023 Dec; 4(4):102165. PubMed ID: 37729058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple Protocol for Generating and Genotyping Genome-Edited Mice With CRISPR-Cas9 Reagents.
    Fernández A; Morín M; Muñoz-Santos D; Josa S; Montero A; Rubio-Fernández M; Cantero M; Fernández J; Del Hierro MJ; Castrillo M; Moreno-Pelayo MÁ; Montoliu L
    Curr Protoc Mouse Biol; 2020 Mar; 10(1):e69. PubMed ID: 32159922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for precision editing of endogenous Chlamydomonas reinhardtii genes with CRISPR-Cas.
    Nievergelt AP; Diener DR; Bogdanova A; Brown T; Pigino G
    STAR Protoc; 2024 Mar; 5(1):102774. PubMed ID: 38096061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR deactivation in mammalian cells using photocleavable guide RNAs.
    Zou RS; Liu Y; Ha T
    STAR Protoc; 2021 Dec; 2(4):100909. PubMed ID: 34746867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of CRISPR-Cas9-generated point mutant mice using MiSeq and locked nucleic acid probe PCR.
    Vasu K; Fox PL
    STAR Protoc; 2021 Dec; 2(4):100785. PubMed ID: 34585153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.